Related Experiment Video

Updated: Jul 1, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

[Chronic kidney disease in children]

Osamu Uemura1, Takuji Yamada, Takuhito Nagai

  • 1Department of Pediatric Nephrology, Aichi Children' s Health and Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 16, 2008
PubMed

Insights

Pediatric chronic kidney disease (CKD) assessment is advancing. Research is standardizing creatinine, cystatin C, and inulin clearance, but randomized trials are needed to confirm adult treatment efficacy in children.

Area of Science:

  • Pediatric Nephrology
  • Biomarker Research
  • Clinical Trial Design

Context:

  • Advancements in chronic kidney disease (CKD) assessment methods globally.
  • Establishment of the Japanese Society for Pediatric Nephrology's Subcommittee of Measures for Pediatric CKD in 2006.
  • Multidisciplinary efforts to define pediatric CKD assessment standards.

Purpose:

  • Determine normal/usual baseline values for serum creatinine and cystatin C in children.
  • Standardize the method for inulin clearance measurement in pediatric populations.
  • Evaluate the efficacy of established adult pharmacotherapies in childhood CKD.

Summary:

  • The Subcommittee is investigating key biomarkers (creatinine, cystatin C) and clearance methods (inulin) for pediatric CKD.
  • While adult treatments like ACE inhibitors and ARBs are used for non-diabetic nephropathy, their efficacy in children with CKD is unproven.
  • A need for a randomized controlled trial to validate these treatments in pediatric CKD is identified.

Impact:

  • Establishing standardized diagnostic criteria for pediatric CKD.
  • Informing evidence-based treatment guidelines for childhood kidney diseases.
  • Potentially improving therapeutic outcomes for children with chronic kidney disease.

More Related Videos

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...